Regarding IGF2BP3, all four pancreatic cancer datasets indicated overexpression in both pancreatic carcinoma and pancreatic ductal adenocarcinoma (Table 1) [12–16]. The gene discussed is IGF2BP3; the disease is familial pancreatic carcinoma.